S-Space

Browse

Subject

Jump to a point in the index

Or type in a year

Sort by
In order
Results/Page
Authors/record

Showing results 1 to 22 of 22

Issue Date	Title / Author(s) / Citation	File
1994-09	Genetic changes in the transforming growth factor beta (TGF-beta) type II receptor gene in human gastric cancer cells: Correlation with sensitivity to growth inhibition by TGF-beta PARK, KC; KIM, SJ; BANG, YJ; PARK, JG; KIM, NK; ROBERTS, AB; SPORN, MB Proceedings of the National Academy of Sciences of the United States of America, Vol.91 No.19, pp.8772-8776	DOI
1997-07	Expression of transforming growth factor β type II receptor reduces tumorigenicity in human gastric cancer cells Chang, Jay; Park, Keunchil; Bang, Yung-Jue; Kim, Won Seog; Kim, David; Kim, Seong-Jin Cancer Research, Vol.57 No.14, pp.2856-2859
1999-04	Truncation of the TGF-β type II receptor gene results in insensitivity to TGF-β in human gastric cancer cells Yang, Han-Kwang; Kang, Shin Hyeok; Kim, Yong-Seok; Won, Kyungshick; Bang, Yung-Jue; Kim, Seong-Jin Oncogene, Vol.18 No.13, pp.2213-2219	DOI
2002-12	MAPK signaling is involved in camptothecin-induced cell death Lee, Seongeun; Lee, Ho-Soon; Baek, Myunginq; Lee, Dae-Yeon; Bang, Yung-Jue; Cho, Hae-Nyun; Lee, Yun-Sil; Ha, Ji-Hong; Kim, Hae-Yeong; Jeong, Doo-Il Molecules and Cells, Vol.14 No.3, pp.348-354
2004-04	Bcl-xL and E1B-19K Proteins Inhibit p53-induced Irreversible Growth Arrest and Senescence by Preventing Reactive Oxygen Species-dependent p38 Activation Jung, Mun-Su; Jin, Dong-Hoon; Chae, Hee-Don; Kang, Seokwon; Kim, Sun-Chang; Bang, Yung-Jue; Choi, Tae-Saeng; Choi, Kyeong-sook; Shin, Deug Y. Journal of Biological Chemistry, Vol.279 No.17, pp.17765-17771	DOI
2004-05	Cdk2-dependent phosphorylation of the NF-Y transcription factor is essential for the expression of the cell cycle-regulatory genes and cell cycle G1/S and G2/M transitions Chae, Hee-Don; Yun, Jaenho; Bang, Yung-Jue; Shin, Deug Y. Oncogene, Vol.23 No.23, pp.4084-4088	DOI
2004-08	Class I histone deacetylase-selective novel synthetic inhibitors potently inhibit human tumor proliferation Park, Jung-Hyun; Jung, Yeonjoo; Kim, Tai Young; Kim, Sang Gyun; Jong, Hyun-Soon; Lee, Jung Weon; Kim, Dae-Kee; Lee, Jong-Soo; Kim, Noe Kyeong; Kim, Tae You; Bang, Yung-Jue Clinical Cancer Research, Vol.10 No.15, pp.5271-5281	DOI
2008-01	Trastuzumab inhibits the growth of human gastric cancer cell lines with HER2 amplification synergistically with cisplatin Kim, Sun Young; Kim, Hwang Phill; Kim, Yu Jung; Oh, Do Youn; Im, Seock-Ah; Lee, Dongsoon; Jong, Hyun-Soon; Kim, Tae-You; Bang, Yung-Jue International Journal of Oncology, Vol.32 No.1, pp.89-95	DOI
2010-04	KRAS Mutant Lung Cancer Cells Are Differentially Responsive to MEK Inhibitor Due to AKT or STAT3 Activation: Implication for Combinatorial Approach Yoon, Young-Kwang; Kim, Hwang-Phill; Han, Sae-Won; Oh, Do Youn; Im, Seock-Ah; Bang, Yung-Jue; Kim, Tae-You Molecular Carcinogenesis, Vol.49 No.4, pp.353-362	DOI
2011-07	Antitumor activity of NVP-AUY922, a novel heat shock protein 90 inhibitor, in human gastric cancer cells is mediated through proteasomal degradation of client proteins Lee, Kyung-Hun; Lee, Ju-Hee; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Oh, Do-Youn; Bang, Yung-Jue Cancer Science, Vol.102 No.7, pp.1388-1395	DOI
2012-10	Treatment of ALK-Positive Non-Small Cell Lung Cancer Bang, Yung-Jue Archives of Pathology and Laboratory Medicine, Vol.136 No.10, pp.1201-1204	DOI
2013-01	Multiplexed Gene Expression and Fusion Transcript Analysis to Detect ALK Fusions in Lung Cancer Lira, Maruja E.; Kim, Tae Min; Huang, Donghui; Deng, Shibing; Koh, Youngil; Jang, Bogun; Go, Heounjeong; Lee, Se-Hoon; Chung, Doo Hyun; Kim, Woo Ho; Schoenmakers, Eric F. P. M.; Choi, Yoon-La; Park, Keunchil; Ahn, Jin Seok; Sun, Jong-Mu; Ahn, Myung-Ju; Kim, Dong-Wan; Mao, Mao Journal of Molecular Diagnostics, Vol.15 No.1, pp.51-61	DOI
2015-11	Targeting stemness is an effective strategy to control EML4-ALK(+) non-small cell lung cancer cells Oh, Se Jin; Noh, Kyung Hee; Lee, Young-Ho; Hong, Soon-Oh; Song, Kwon-Ho; Lee, Hyo-Jung; Kim, Soyeon; Kim, Tae Min; Jeon, Ju-Hong; Seo, Jae Hong; Kim, Dong-Wan; Kim, Tae Woo Oncotarget, Vol.6 No.37, pp.40255-40267	view file DOI
2017-02	Vandetanib in pretreated patients with advanced non-small cell lung cancer-harboring RET rearrangement: a phase II clinical trial Lee, Se-Hoon; Lee, J. -K.; Ahn, M. -J.; Kim, D. -W.; Sun, J. -M.; Keam, B.; Kim, T. M.; Heo, D. S.; Ahn, J. S.; Choi, Y. -L.; Min, H. -S.; Jeon, Y. K.; Park, K. Annals of Oncology, Vol.28 No.2, pp.292-297	DOI
2018-05	Phase II study of crizotinib in east asian patients with ROS1-positive advanced non–small-cell lung cancer Wu, Yi-Long; Yang, James Chih-Hsin; Kim, Dong-Wan; Lu, Shun; Zhou, Jianying; Seto, Takashi; Yang, Jin-Ji; Yamamoto, Noboru; Ahn, Myung-Ju; Takahashi, Toshiaki; Yamanaka, Takeharu; Kemner, Allison; Roychowdhury, Debasish; Paolini, Jolanda; Usari, Tiziana; Wilner, Keith D.; Goto, Koichi Journal of Clinical Oncology, Vol.36 No.14, pp.1405-1411	DOI
2019-08	Enhanced antitumor effect of binimetinib in combination with capecitabine for biliary tract cancer patients with mutations in the RAS/RAF/MEK/ERK pathway: Phase Ib study Kim, Jin Won; Lee, Kyung-Hun; Kim, Ji-Won; Suh, Koung Jin; Nam, Ah-Rong; Bang, Ju-Hee; Bang, Yung-Jue; Oh, Do-Youn British Journal of Cancer, Vol.121 No.4, pp.332-339	DOI
2019-09	Preclinical Modeling of Osimertinib for NSCLC With EGFR Exon 20 Insertion Mutations Lee, Yusoo; Kim, Tae Min; Kim, Dong-Wan; Kim, Soyeon; Kim, Miso; Keam, Bhumsuk; Ku, Ja-Lok; Heo, Dae Seog Journal of Thoracic Oncology, Vol.14 No.9, pp.1556-1566	DOI
2020-01	Therapeutic Co-targeting of WEE1 and ATM Downregulates PD-L1 Expression in Pancreatic Cancer Jin, Mei Hua; Nam, Ah-Rong; Park, Ji Eun; Bang, Ju-Hee; Bang, Yung-Jue; Oh, Do-Youn Cancer Research and Treatment, Vol.52 No.1, pp.149-166	view file DOI
2020-02	Safety, Pharmacokinetics, and Clinical Activity of Adavosertib in Combination with Chemotherapy in Asian Patients with Advanced Solid Tumors: Phase Ib Study Kato, Hidenori; de Souza, Paul; Kim, Sang-We; Lickliter, Jason D.; Naito, Yoichi; Park, Keunchil; Kumar, Sanjeev; Mugundu, Ganesh M.; Bang, Yung-Jue Targeted Oncology, Vol.15 No.1, pp.75-84	DOI
2020-06	Antitumor effect of a WEE1 inhibitor and potentiation of olaparib sensitivity by DNA damage response modulation in triple-negative breast cancer Ha, Dong-Hyeon; Min, Ahrum; Kim, Seongyeong; Jang, Hyemin; Kim, So Hyeon; Kim, Hee-Jun; Ryu, Han Suk; Ku, Ja-Lok; Lee, Kyung-Hun; Im, Seock-Ah Scientific Reports, Vol.10 No.1, p. 9930	DOI
2020-07	Inhibition of ATR Increases the Sensitivity to WEE1 Inhibitor in Biliary Tract Cancer Nam, Ah-Rong; Jin, Mie-Hua; Bang, Ju-Hee; Oh, Kyoung-Seok; Seo, Hye-Rim; Oh, Do-Youn; Bang, Yung-Jue Cancer Research and Treatment, Vol.52 No.3, pp.945-956	view file DOI
2023-01	The antitumor activity of a novel GCN2 inhibitor in head and neck squamous cell carcinoma cell lines Lee, Jeongjae; Keam, Bhumsuk; Kim, Soyeon; Heo, Jung-Nyoung; Joung, Eunkyo; Kim, Miso; Kim, Tae Min; Kim, Dong-Wan; Heo, Dae Seog Translational Oncology, Vol.27, p. 101592	DOI